Taiflex Scientific revenue and financials
$304.50Change from previous close: +3.05%Absolute change: +$9.00
In the fiscal year ended December 2025, Taiflex Scientific reported revenue of $10.61B (+6.75% year over year). Net income was $535.12M, a net margin of 5.0%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +6.75%
- 2025 vs 2024
- Net income growth
- −9.73%
- 2025 vs 2024
- Net margin
- 5.0%
- 2024: 6.0%
Financial data
Amounts in millions of TWD; per-share values in TWD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | 14,767 | 14,527 | 13,031 | 12,848 | — |
| Current assets | 9,283 | 8,776 | 7,375 | 7,913 | — |
| Cash and equivalents | 2,878 | 2,889 | 1,965 | 2,264 | — |
| Short-term investments | 36.6 | 232 | 32.7 | 57.7 | — |
| Inventory | 1,814 | 1,652 | 1,410 | 1,771 | — |
| Net property, plant and equipment | 4,837 | 5,010 | 4,892 | 4,287 | — |
| Long-term investments | 7.5 | 10.3 | 15.2 | 27.5 | — |
| Current liabilities | 3,159 | 2,826 | 4,103 | 2,069 | — |
| Accounts payable | 1,408 | 1,332 | 1,042 | 752 | — |
| Long-term debt | 255 | 570 | 346 | 2,179 | — |
| Total debt | 920 | 1,195 | 2,778 | 2,785 | — |
| Total liabilities | 3,846 | 3,862 | 4,963 | 4,795 | — |
| Total equity (incl. minority) | 10,921 | 10,666 | 8,069 | 8,052 | — |
| Retained earnings | 4,217 | 4,211 | 3,561 | 3,661 | — |
| Minority interest | 24.9 | 21.5 | 81.3 | 144 | — |